Outcome of medical therapy for keratomalacia in dogs. (17th February 2020)

• Record Type: Journal Article
• Authors: Guyonnet, A.; Desquilbet, L.; Faure, J.; Bourguet, A.; Donzel, E.; Chahory, S.
• Is Part Of: Journal of small animal practice. Volume 61:Number 4(2020)
• Page Start: 253
• Page End: 258
• Publication Date: 2020-02-17
• Subjects: Veterinary medicine -- Periodicals; Veterinary Medicine -- Periodicals; 636.089
• DOI: 10.1111/jsap.13118
• Languages: English
• ISSNs: 0022-4510

Abstract

Abstract : Objectives: To evaluate the clinical and visual outcomes following intensive medical therapy for keratomalacia in dogs. Materials and Methods: Medical records were screened to identify dogs with corneal ulcers and keratomalacia. All patients were given the same topical treatment protocol with frequent administrations of tobramycin in combination with equine serum. Surgical treatment during the first 15 days of follow‐up was considered as medical treatment failure. Results: We report on 57 ulcers with keratomalacia from 53 dogs. Medical treatment was successful in 31 of 57 ulcers with a median healing time of 5 days (range 2 to 15 days). At 60 days after epithelialisation, 14/15 medically‐treated eyes were visual. In one case, corneal perforation was observed 1 month after healing and required surgical stabilisation. Clinical Significance: Intensive medical therapy has the potential to achieve healing of some ulcers with keratomalacia. Surgical stabilisation in response to progression of stromal loss was required in less than half of the cases.